Literature DB >> 28550068

Age-specific trends of atrial fibrillation-related ischaemic stroke and transient ischaemic attack, anticoagulant use and risk factor profile in Chinese population: a 15-year study.

Yannie Soo1, Nathan Chan1, Kam Tat Leung1, Xiang-Yan Chen1, Vincent Mok1, Lawrence Wong1, Thomas Leung1.   

Abstract

BACKGROUND: Prevalence of atrial fibrillation (AF) is increasing globally, and the fivefold increase in stroke risk constitutes significant healthcare burden. AIMS: We aim to evaluate the trends of AF-related stroke and transient ischaemic attack (AF-stroke/TIA), prior anticoagulant use and their risk factors in different age groups in Chinese population.
METHODS: Data were retrieved from the stroke registry at Prince of Wales Hospital. We compared the data at 5-year intervals over a 15-year period (years 1999, 2004, 2009 and 2014).
RESULTS: A total of 3894 patients were included, 712 patients had AF-stroke/TIA. Over the 15 years, the total number of ischaemic stroke/TIA fluctuated slightly during the period from year 1999 to 2009, and increased by 21.5% in the year 2014. While AF-stroke/TIA increased continuously with time by 282.1%. Increasing trend of AF-stroke/TIA was observed in all age groups. Absolute growth was highest in patients aged ≥80 years; relative growth was most pronounced in those between 65 and 72 years (>3.5 fold increase). Throughout the 15 years, >70% of AF-stroke/TIA occurred in non-anticoagulated patients, and this proportion increased with age. Increasing trends in both hypertension and ischaemic heart disease were also observed in patients with AF aged ≥73 years.
CONCLUSION: AF-stroke/TIA has increased continuously by >2.5 fold in Chinese population over a 15-year period, with the majority of AF-stroke/TIA occurring in non-anticoagulated patients. Strategic planning is needed to optimise anticoagulant use, particularly non-vitamin K antagonist oral anticoagulants in elderly patients, low-income group and those with ischaemic heart disease requiring concomitant antiplatelet therapy. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Trends; age; anticoagulant.; atrial fibrillation; stroke

Mesh:

Substances:

Year:  2017        PMID: 28550068     DOI: 10.1136/jnnp-2017-315735

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  4 in total

1.  Uptake in antithrombotic treatment and its association with stroke incidence in atrial fibrillation: insights from a large German claims database.

Authors:  Stefan H Hohnloser; Edin Basic; Michael Nabauer
Journal:  Clin Res Cardiol       Date:  2019-02-15       Impact factor: 5.460

2.  A 10 year study of hospitalized atrial fibrillation-related stroke in England and its association with uptake of oral anticoagulation.

Authors:  J Campbell Cowan; Jianhua Wu; Marlous Hall; Andi Orlowski; Robert M West; Chris P Gale
Journal:  Eur Heart J       Date:  2018-08-21       Impact factor: 35.855

3.  Potential Target Genes in the Development of Atrial Fibrillation: A Comprehensive Bioinformatics Analysis.

Authors:  Liang Liu; Yun Yu; Long-Long Hu; Quan-Bin Dong; Feng Hu; Ling-Juan Zhu; Qian Liang; Ling-Ling Yu; Hui-Hui Bao; Xiao-Shu Cheng
Journal:  Med Sci Monit       Date:  2021-03-20

4.  2021 Asia Pacific Heart Rhythm Society (APHRS) practice guidance on atrial fibrillation screening.

Authors:  Ngai-Yin Chan; Jessica Orchard; Michael-Joseph Agbayani; Dean Boddington; Tze-Fan Chao; Sofian Johar; Bobby John; Boyoung Joung; Saravanan Krishinan; Rungroj Krittayaphong; Sayaka Kurokawa; Chu-Pak Lau; Toon Wei Lim; Pham Tran Linh; Vien Hoang Long; Ajay Naik; Yasuo Okumura; Tetsuo Sasano; Bernard Yan; Sunu Budhi Raharjo; Dicky Armein Hanafy; Yoga Yuniadi; Nwe Nwe; Zahid Aslam Awan; He Huang; Ben Freedman
Journal:  J Arrhythm       Date:  2021-12-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.